Bear Stearns Downgrades Momenta Pharmaceuticals (MNTA) to Peer Perform
More News related to MNTA
- Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2008 Financial Results
- BeaconEquity.com Issues TraderNotes on Active Stocks: SPSN, CHCG, DTPI, AMKR, TQNT, MNTA, CBPC, ABAT
- Unusual 11 Mid-Day Movers 7/11: HPC, DTPI, HYGS, SPSN Higher; RDN, TUES, FNM, FRE Lower
- Momenta Pharmaceuticals Announces Filing of Abbreviated New Drug Application With a Paragraph IV Certification for Generic Version of Copaxone
- Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
Bear Stearns downgrades Momenta Pharmaceuticals (Nasdaq: MNTA) from Outperform to Peer Perform.
Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the structural analysis of complex mixture drugs. [BCS]
Related Categories
DowngradesStocks Mentioned
+0.62Related Entities
Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
